Cannara Biotech (TSXV:LOVE) FCF Yield % : -0.27 (As of May. 24, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Cannara Biotech's Trailing 12-Month Free Cash Flow is C$-0.19 Mil, and Market Cap is C$71.12 Mil. Therefore, Cannara Biotech's FCF Yield % for today is -0.27%.

The historical rank and industry rank for Cannara Biotech's FCF Yield % or its related term are showing as below:

TSXV:LOVE' s FCF Yield % Range Over the Past 10 Years
Min: -56.06 Med: -24.79 Max: -0.22
Current: -0.27

During the past 6 years, the highest FCF Yield % of Cannara Biotech was -0.22%. The lowest was -56.06%. And the median was -24.79%.

TSXV:LOVE's FCF Yield % is ranked better than
50.88% of 1083 companies
in the Drug Manufacturers industry
Industry Median: -0.47 vs TSXV:LOVE: -0.27

Cannara Biotech's FCF Margin % for the quarter that ended in Feb. 2024 was 6.18%.

Cannara Biotech FCF Yield % Historical Data

The historical data trend for Cannara Biotech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech FCF Yield % Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

FCF Yield %

Get a 7-Day Free Trial

-28.03

-26.60

-22.26

-18.20

-4.92

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
FCF Yield %	Get a 7-Day Free Trial															-6.84	-0.18	4.67	-13.27	5.51

Competitive Comparison of Cannara Biotech's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's FCF Yield % falls into.

Cannara Biotech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Cannara Biotech's FCF Yield % for the fiscal year that ended in Aug. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-4.442	/	90.3058
	=	-4.92%

Cannara Biotech's annualized FCF Yield % for the quarter that ended in Feb. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	1.216	*	4	/	88.21862
	=	5.51%

Cannara Biotech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Cannara Biotech FCF Yield % Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives